Finance

Lists
600332:SHA
Guangzhou Baiyunshan Pharmaceutical Holdings Ord Shs A
CNÂ¥19.73
-0.75%
(-0.15) 1D
Sep 11, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600332...
Open
CNÂ¥19.83
High
CNÂ¥19.87
Low
CNÂ¥19.56
Mkt. cap
30.48B
Avg. vol.
9.05M
Volume
7.29M
Dividend
3.80%
Quarterly dividend
CNÂ¥0.19
Ex-dividend date
Jun 16, 2026
P/E ratio
10.89
52-wk high
CNÂ¥27.50
52-wk low
CNÂ¥19.30
EPS
CNÂ¥1.81
Shares outstanding
1.41B
No. of employees
26K
Open
CNÂ¥19.83
High
CNÂ¥19.87
Low
CNÂ¥19.56
Mkt. cap
30.48B
Avg. vol.
9.05M
Volume
7.29M
Dividend
3.80%
Quarterly dividend
CNÂ¥0.19
Ex-dividend date
Jun 16, 2026
P/E ratio
10.89
52-wk high
CNÂ¥27.50
52-wk low
CNÂ¥19.30
EPS
CNÂ¥1.81
Shares outstanding
1.41B
No. of employees
26K
About Guangzhou Baiyunshan Pharmaceutical Holdings Ord Shs A
CEO-
Employees26.4K
FoundedSep 1, 1997
Headquarters-
SectorHealth care provider
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
19.77B
16.05B
23.28B
18.81B
Cost of goods sold
16.58B
14.37B
18.55B
16.29B
Cost of revenue
16.58B
14.37B
18.55B
16.29B
Research and development expenses
158.44M
217.91M
158.68M
184.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.88B
2.21B
2.22B
1.83B
Operating expense
2.05B
2.50B
2.55B
2.11B
Total operating expenses
18.63B
16.87B
21.10B
18.40B
Operating income
1.14B
-820.04M
2.18B
409.74M
Other non operating income
83.07M
-100.40M
-1.28M
-15.15M
EBT including unusual items
1.09B
-494.18M
2.21B
393.99M
EBT excluding unusual items
1.24B
-825.17M
2.21B
377.21M
Income tax expense
271.49M
-156.77M
383.93M
59.00M
Effective tax rate
24.82%
31.72%
17.39%
14.97%
Other operating expenses
-46.93M
164.17M
91.90M
62.67M
Net income
793.91M
-326.94M
1.78B
312.16M
Net profit margin
4.02%
-2.04%
7.66%
1.66%
Earnings per share
-
-
-
-
Interest and investment income
117.54M
187.01M
140.88M
97.52M
Interest expense
-101.91M
-95.60M
-103.44M
-110.76M
Net interest expenses
15.64M
91.41M
37.44M
-13.24M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.29B
-660.36M
2.34B
583.55M
Gain or loss from assets sale
3.63M
-107.74M
-
-938.61K
AI content may include mistakes. Learn more
Google apps